Health BRIEFS : vimarsana.com

Cadila Pharma phase I clinical trial for chicken pox shot: SEC recommends nod FOR trial

The Subject Expert Committee (SEC) on vaccines, which reviews proposals and advises the Drugs Controller General (India) in matters for biologicals and post approval change proposals, has recommended granting

Related Keywords

India , Bangalore , Karnataka , Ahmedabad , Gujarat , Jaxay Shah , Jason Akulian , Cadila Pharma , Mohan Kochhar , Cadila Pharmaceuticals , National Accreditation Board For Hospitals , World Health Organisation , Neuberg Supratech Reference Laboratory , Department Of Medicine , Expert Committee , Quality Council Of India , University Of North Carolina , Neuberg Anand Reference Laboratory , Vanderbilt University , Digital Health Accreditation Standards For Hospitals , Neuberg Diagnostics Private , Subject Expert Committee , Drugs Controller General , Gujarat Based Cadila Pharmaceuticals , Varicella Zoster Virus , New Drugs , Clinical Trials Rules , North Carolina , Chapel Hill , Science Robotics , Quality Council , Digital Health Accreditation Standards , National Accreditation Board , Healthcare Providers , Entry Level Certification Standards , Dental Clinics , Care Home Accreditation Standards , Accreditation Standards , Dental Service Providers , Atul Mohan Kochhar , Diagnostics Private Limited , Neuberg Diagnostic , Neuberg Diagnostics , Health Briefs ,